SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.11+0.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (6459)12/11/1998 2:40:00 PM
From: Anthony Wong  Read Replies (1) of 9523
 
European Commission Committee Approves Ban on Feed Additives

Bloomberg News
December 11, 1998, 12:51 p.m. ET

European Commission Committee Approves Ban on Feed Additives

Brussels, Dec. 11 (Bloomberg) -- A European Commission
committee voted to ban two chemicals used as additives in animal
feed in a decision that could raise farm costs just as producers
face plunging incomes.

The European Commission is expected to formally approve the
standing committee for animal nutrition's decision next week,
officially banning carbadox and olaquindox, which are both used to
boost growth in livestock.

The ban, which is part of EU Agriculture Commissioner Franz
Fischler's efforts to improve food safety, would come as commodity
prices have slid because of rising inventories and the loss of
Russian and Asian exports. In November, British farm leaders said
U.K. farm incomes fell by more than 50 percent in 1998.

Four antibiotics have already been banned from use as feed
additives, citing concern that humans could become immune to
certain medicines after eating meat from animals fed with
antibiotics.

The two feed additives could pose a risk of cancer in humans
preparing the feed and giving it to the animals, Fischler said
when he proposed the ban last week. Enough committee members in
today's vote approved the plan, signaling formal approval is
likely next week.

Spokesmen for Bayer AG, which originally patented olaquindox,
and Pfizer Corp., which originally developed carbadox, said last
week they wouldn't be badly affected by a ban, since the patents
on the products have expired and most are now produced by other
companies outside the EU.

--Anne Brockhoff in the London newsroom (44 171) 330-7100/tc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext